Podcast appearances and mentions of Jason Hall

Send us a textA new breast implant called Motiva has been all over social media — but is it really the next big thing in plastic surgery or just a risky experiment?In this 100th episode of The Trillium Show, Dr. Jason Hall breaks down the hype behind Motiva implants and what sets them apart: from their RFID microchip tracker to their promise of near-zero capsular contracture rates. But as Dr. Hall explains, lower contracture rates may come with trade-offs — including a surprising 50% rate of implant malposition in early studies.You'll learn:The real science behind Motiva's “smart” implant designWhy less scar tissue around the implant isn't always a good thingThe hidden risks of early adoption in medical technologyHow surgeons choose implants, handle consignment stock, and keep costs down for patientsIf you're considering breast augmentation — or just want the truth about the latest “must-have” device trending online — this episode is a must-watch before you book your consult.

Hola Gerardo aquí en otro episodio de Simplemente Yo; La selección de esta semana es Gran Turismo, es una película biográfica estadounidense de drama deportivo de 2023 basada en la serie de videojuegos de simulación de carreras desarrollada por Polyphony Digital. Producida por Columbia Pictures, PlayStation Productions y 2.0 Entertainment, la película fue dirigida por Neill Blomkamp a partir de un guion de Jason Hall y Zach Baylin.   Plot: Basada en la increíble e inspiradora historia real de un equipo de perdedores: un jugador de clase trabajadora , un ex piloto de carreras fracasado y un ejecutivo de deportes de motor idealista, que lo arriesgan todo para enfrentarse al deporte más elitista del mundo de carreras.   Espero que lo disfruten ;)   Información adicional del podcast: Enlace del website official de Filmic Notion Podcast: https://filmicnotionpod.com/ Enlace a nuestra página de Letterboxd: https://boxd.it/446nl  

Chinese stocks are back in the headlines, and we're putting them on trial. Motley Fool Money flips the script as Jason Hall steps into the host chair to referee a fast-paced bull/bear debate between longtime China investor Emily Flippen and resident skeptic Toby Bordelon. On today's show, Emily, Jason, and Toby: - Go head-to-head on PDD Holdings - Debate whether Baidu can self-drive its future - Do a speed round between Weibo and iQiYi - deep value or value traps? Companies discussed: BIDU, PDD, WB, IQ Host: Emily Flippen, Jason Hall, Toby Bordelon Producer: Anand Chokkavelu Engineer: Dan Boyd Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. We're committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode. Learn more about your ad choices. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

We're mashing up quantum computing, AI infrastructure, and space stocks as we dig into a handful of headline-grabbing earnings reports. From GPU farms on the ground to satellites in orbit, we're asking what's investable now… and what still belongs in the “sci-fi someday” bucket. Emily Flippen, Jason Hall, and Keith Speights: - Break down CoreWeave's latest results, including booming backlog, heavy capex, and whether an AI infrastructure arms race can still reward shareholders. - Compare CoreWeave's reality to “up-and-coming” quantum names like Rigetti, IonQ, D-Wave, and QUBT – and make the case for (or against) taking the tech-giant route with Alphabet or Microsoft instead. - Explain why Rocket Lab's record revenue, rising margins, and growing backlog are bright spots in a bruised space sector – and how government shutdown drama factors into the story. - Dig into AST SpaceMobile's satellite-to-cell strategy, big-name carrier partners, ambitious launch plans, and why 2026 could be a make-or-break year for the stock. Companies discussed: CRWV, RGTI, RKLB, SPCE, ASTS Host: Emily Flippen, Jason Hall, Keith Speights Producer: Anand Chokkavelu Engineer: Dan Boyd Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. We're committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode. Learn more about your ad choices. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Wall Street didn't take kindly to the financial reports from Axon, Trex, and Warby Parker. Should investors be buying amid the bloodbath? We answer that question on today's show. Emily Flippen, Jason Hall, and Tim Beyers: - Report what Wall Street didn't like about AXON, TREX, and WRBY earnings. - Make a buy, sell, or hold call on each stock. - Play another game of Faker or Breaker. Don't wait! Be sure to get to your local bookstore and pick up a copy of David's Gardner's new book — Rule Breaker Investing: How to Pick the Best Stocks of the Future and Build Lasting Wealth. It's on shelves now; get it before it's gone! Companies discussed: AXON, TREX, WRBY, ACHR, HIPO, SKY Host: Tim Beyers Guests: Emily Flippen, Jason Hall Producer: Anand Chokkavelu Engineer: Dan Boyd Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. We're committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode. Learn more about your ad choices. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Spotify, Shopify, and Uber were once the poster children for “growth at any cost.” Today, they're talking cash flow, margins, and discipline. In today's episode of Motley Fool Money, host Emily Flippen is joined by analysts Jason Hall and Jeff Santoro to dig into what these “reformed Rule Breakers” are getting right - and where the risks still lurk. They discuss third quarter earnings reports for: - Shopify and how its business stacks up against Amazon and agentic shopping in the battle for online commerce. - Spotify's margin makeover, and how the business has created scale in an industry many were skeptical of - Uber's transformation from “broken IPO” to cash-flow machine, and how its pricing algorithm has unlocked margin potential Companies discussed: SHOP, SPOT, UBER, GRAB Host: Emily Flippen, Jason Hall, Jeff Santoro Producer: Anand Chokkavelu Engineer: Dan Boyd, Natasha Hall Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. We're committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode. Learn more about your ad choices. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Host Emily Flippen is joined by Motley Fool analysts Jason Hall and Keith Speights to unpack how a prolonged U.S. government shutdown ripples through markets - from missing economic reports and the Fed's next move to the on-the-ground impact for contractors, biotechs, and housing. Companies discussed: NOC, PLTR, BAH, ACN, MSFT, LLY, AMTM Host: Emily Flippen, Jason Hall, Keith Speights Producer: Anand Chokkavelu Engineer: Dan Boyd Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. We're committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode. Learn more about your ad choices. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

We discuss how cloud outages may impact stocks beyond Amazon. Plus, GM's great results may show how weak EV sales will be in the U.S. and the how Co-CEO roles have become so popular in tech. Travis Hoium, Lou Whiteman, and Jason Hall discuss: - Cloud outages - GM's results and the EV future - The rise of the co-CEO - Apple's iPhone growth Companies discussed: Apple (AAPL), Amazon (AMZN), Alphabet (GOOG, GOOGL), General Motors (GM), Tesla (TSLA), NVIDIA (NVDA), General Electric (GE), Walmart (WMT), Meta (META), Netflix (NFLX). Host: Travis Hoium Guests: Lou Whiteman, Jason Hall Engineer: Dan Boyd Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. We're committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode. Learn more about your ad choices. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us a textThere's a new surgeon in the Trillium Plastic Surgery office! And today, you get to meet her.In this episode, Dr. Jason Hall sits down with Dr. Jessica Walker, a double board-certified plastic surgeon with extensive training in general and plastic surgery. After years of high-intensity trauma work in Detroit, Dr. Walker found her calling in aesthetic breast and body surgery, work that's taken on even deeper meaning since becoming a mom herself.She opens up about her personal fertility journey, balancing motherhood with medicine, and how those experiences have shaped the way she connects with her patients. Dr. Hall and Dr. Walker also discuss:What makes an ideal tummy tuck candidateThe truth about “drainless” abdominoplasty techniquesWhy general surgery training is invaluable for plastic surgeonsHow motherhood changes the way surgeons think about their workGet to know the newest member of the Trillium team and learn what sets her approach apart, both in and out of the operating room.Follow Dr. Walker on Instagram (@dr.jessica_walker) and learn more about Trillium Plastic Surgery or book your consultation with Dr. Jason Hall or Dr. Jessica Walker here: https://drjasonhall.com/

Prediction markets are having a moment - from Fed odds to football. In this episode of Motley Fool Money, host Emily Flippen, with analysts Jason Hall and Sanmeet Deo, break down what prediction markets are, why they exploded, how regulators view them, and the smartest ways investors might (or might not) get exposure. Companies discussed: HOOD, ICE Host: Emily Flippen, Jason Hall, Sanmeet DeoProducer: Anand ChokkaveluEngineer: Bart Shannon Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit ⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Motley Fool Money, long-time analysts Emily Flippen, Jeff Santoro, and Jason Hall dive into bank earnings, Robinhood's meteoric rise, and take a look at how alcohol consumption has changed the landscape for vice investments. Companies discussed: JPM, GS, WFC, HOOD, STZ, SAM Host: Emily Flippen, Jason Hall, Jeff Santoro Producer: Anand Chokkavelu Engineer: Dan Boyd Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. We're committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode. Learn more about your ad choices. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us a textThink fat in your neck is something to get rid of? Think again. In this episode of The Trillium Show, Dr. Jason Hall explains why a little fat in the right places is essential for youthful, elegant facial contours—and why destroying it with trendy non-surgical treatments like Kybella, CoolSculpting, or radiofrequency tightening can actually make future surgery more difficult and less effective.He breaks down the science behind neck contouring, the long-term risks of fat-dissolving treatments, and what you should know before booking any “quick fix” procedure. Whether you're considering facial rejuvenation now or years from now, this conversation will help you make smarter, safer choices for lasting beauty.

As Prime Day kicks off, we're asking the big questions. Emily Flippen is joined by Jason Hall and Dan Caplinger to tackle three timely stories: - Whether 2025's tariff push is actually “working” (and who's really paying) - How a U.S. sale of TikTok could reshape social commerce just as Amazon's big event feels less special - What the Sept. 30 expiration of federal EV tax credits means for demand at Tesla, BYD, Ford, and beyond - Plus, a lightning round of stocks positioned to benefit from these trends Companies discussed: AMZN, PDD, TSLA, BYDDY, F, SYM Host: Emily Flippen, Jason Hall, Dan Caplinger Producer: Anand Chokkavelu Engineer: Dan Boyd Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. We're committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode. Learn more about your ad choices. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Jeff Santoro is an educator from New Jersey and Jason Hall is a financial writer and analyst. Together they host the Investing Unscripted podcast. We talk about getting wise to saving, music, and even engage in a little stock picking.    Investing Unscripted West Windsor-Plainsboro Regional School District Learned by Being Burned (short pod series about K-12 403(b) issues) 403bwise.org Meridian Wealth Management Nothing presented or discussed is to be construed as investment or tax advice. This can be secured from a vetted Certified Financial Planner (CFP®). 

American palates are shifting, and investors are starting to take notice. In today's episode of Motley Fool Money, host Emily Flippen is joined by analysts Sanmeet Deo and Jason Hall to unpack four of the newest Asian food chains looking to expand across the United States The team dives into: - Whether or not Jollibee's rise is sustainable - The re-emergence of Luckin Coffee and changing consumer tastes - If the experiential dining of Kura Sushi and Haidilao Hot Pot are replicable - Which chain offers investors the best opportunity today Companies discussed: JBFCF, LKNCY, KRUS, HDALF Host: Emily Flippen, Jason Hall, Sanmeet Deo Producer: Anand Chokkavelu Engineer: Dan Boyd Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. We're committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode. Learn more about your ad choices. Visit ⁠⁠⁠⁠⁠⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us a textThinking about plastic surgery? Don't pick a surgeon until you've heard this. In this solo episode of The Trillium Show, board-certified plastic surgeon Dr. Jason Hall pulls back the curtain on the cosmetic industry's marketing hype to give you an honest, practical roadmap for selecting the right surgeon for you.You'll learn:How to tell if a “cosmetic surgeon” is actually trained in surgeryWhy hospital privileges matter more than flashy social mediaWhat to watch for in before-and-after photos and online reviewsHow pricing, personality, and complications factor into your decisionDr. Hall even shares a free downloadable checklist you can take to consultations to help you make a confident, informed choice.Get the download here: https://drjasonhall.mykajabi.com/surgeonchecklist

On today's episode of Motley Fool Money, analysts Emily Flippen, Jason Hall, and Toby Bordelon spotlight three off-the-radar small caps with very different stories. The team dives into: - Why the renewable energy industry deserves a second look, even with policy headwinds - If Phinia offers a pragmatic hedge against a slower-than-expected EV transition - A rapidly expanding premium Chinese tea-house that has changing unit economics Companies discussed: ENPH, FLNC, PHIN, TSLA, CHA, LKNCY Host: Emily Flippen, Jason Hall, Toby Bordelon Producer: Anand Chokkavelu Engineer: Bart Shannon, Dan Boyd Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. We're committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode. Learn more about your ad choices. Visit ⁠⁠⁠⁠⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Join Ellen & birder and science communicator Jason Hall for a review of a little bird full of big surprises: the American dipper.  We discuss birding pre-smartphone, Philadelphia's role in ornithological history, the wild physiological adaptations that let this tiny songbird brave mountain rapids, smooth dance moves, aura farming, and so much more.Links:Follow Jason on Instagram: @thebirdingbeardsmanCheck out Jason's podcast, The Bird Joy Podcast!Get involved in nature with In Color Birding!For more information about us & our podcast, head over to our website!Follow Just the Zoo of Us on BlueSky, Facebook, Instagram & Discord!Follow Ellen on BlueSky!Sound credits:Brown-headed cowbird: Thomas Magarian, XC527674. Accessible at www.xeno-canto.org/527674.American dipper: Ted Floyd, XC460525. Accessible at www.xeno-canto.org/460525.Swainson's thrush: Stanislas Wroza, XC1014351. Accessible at www.xeno-canto.org/1014351. 

Send us a textWe've all heard about the dramatic weight-loss results from drugs like Ozempic®, Wegovy®, semaglutide, and tirzepatide, but what aren't you hearing about? In this episode of The Trillium Show, board-certified plastic surgeon Dr. Jason Hall explains the under-the-radar effects these GLP-1 medications can have on your face and skin, including accelerated volume loss, thinning, and changes to your skin's ability to rejuvenate itself.Dr. Hall breaks down:Why these drugs can dramatically change your skin qualityWhat treatments (fat transfer, fillers, lasers, etc.) may help combat this and their limitationsHow to protect your muscle mass and skin health if you're taking or considering GLP-1sIf you're curious about the real impact of GLP-1 medications on aging skin, this episode is a must-listen.

Join Ellen & birder and science communicator Jason Hall for a review of a little bird full of big surprises: the American dipper.  We discuss birding pre-smartphone, Philadelphia's role in ornithological history, the wild physiological adaptations that let this tiny songbird brave mountain rapids, smooth dance moves, aura farming, and so much more.Links:Follow Jason on Instagram: @thebirdingbeardsmanCheck out Jason's podcast, The Bird Joy Podcast!Get involved in nature with In Color Birding!For more information about us & our podcast, head over to our website!Follow Just the Zoo of Us on BlueSky, Facebook, Instagram & Discord!Follow Ellen on BlueSky!Sound credits:Brown-headed cowbird: Thomas Magarian, XC527674. Accessible at www.xeno-canto.org/527674.American dipper: Ted Floyd, XC460525. Accessible at www.xeno-canto.org/460525.Swainson's thrush: Stanislas Wroza, XC1014351. Accessible at www.xeno-canto.org/1014351. 

Parting is such sweet sorrow. Today on Motley Fool Money, Rick Munarriz, with analysts Lou Whiteman and Jason Hall discuss selling decisions they wish they could have back. They also look at some stocks that could thrive in the new normal after last week's problematic jobs report. There's also a sporty look at some of this year's biggest winners and losers. They unpack: - Painful decisions to sell that continue to haunt them. - Three stocks that should move higher as the Fed nudges rates lower. - A game that separates this year's risers from sinkers. Companies discussed: AX, L, MSFT, NFLX, SBUX, MEG, ZG, TSLA, NVDA, Host: Rick Munarriz, Jason Hall, Lou Whiteman Producer: Anand Chokkavelu Engineer: Dan Boyd Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. We're committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode. Learn more about your ad choices. Visit ⁠⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

It's never too late to make the right investing decision. Today on Motley Fool Money, Rick Munarriz, with analysts Tim Beyers and Jason Hall dig into a document database developer and a cybersecurity leader that they believe can keep beating the market. There's also a short-form look at three long-term opportunities with an improv game that has a stock market bent. They unpack: - A stock that soared 44% last week, but can keep moving higher in the long run. - A cybersecurity leader that has bounced back after a whopper of a blunder last summer. - The bullish case for three stocks, one point at a time. Companies discussed: MDB, CRWD, S, MELI, DUOL, WRBY Host: Rick Munarriz, Tim Beyers, Jason Hall Producer: Anand Chokkavelu Engineer: Dan Boyd Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit ⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

It's This Month in Birding for August 2025 and, as we do at the end of every month, we've got a great panel of birders to discuss the month's birding news and scientific publications. Jason Hall, Mikko Jimenez, and Jordan Rutter join host Nate Swick to talk about grackle behavior, museums, and our very favorite penguins.  Links to articles discussed in this episode: The Rodrigues parakeet's last day: What one extinct bird tells us about the role of museums Exploration and dispersal are key traits involved in rapid range expansion, urban bird study finds Conservation sweet spots: How protecting nature helps both birds and humans in the US Fighting isn't sexy in lekking greater sage-grouse: a relational event model approach for mating interactions Dagger beaks and strong wings: New fossils rewrite the penguin story and affirm NZ as a cradle of their evolution Subscribe to the podcast at Apple Podcasts, Spotify, or wherever you get your podcasts and please leave a rating or a review if you are so inclined! We appreciate it!

Lower interest rates are more than a macro headline - for some businesses, what the Federal Reserve decides to do plays an integral role for both management and investors. Today on Motley Fool Money, analysts Emily Flippen, Jason Hall, and David Meier debate the stocks most likely to be impacted after Federal Reserve Chair Jerome Powell's speech at Jackson Hole Companies discussed: WD, RKT, GRBK, O, PYPL, ABNB, PAYC, TSLA Host: Emily Flippen, Jason Hall, David Meier Producer: Anand Chokkavelu Engineer: Bart Shannon Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit ⁠⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

There are new ways to tackle weight loss, but the stocks leading the way are lagging. Today on Motley Fool Money, Rick Munarriz, with analysts Karl Thiel and Jason Hall dig into the problems with weight loss stocks. There's also a look at some investments that can survive next month's potential volatility as well as a long-term view at disruptors of the future that you probably didn't see coming.  They unpack: Three companies that can ride high through what could be a volatile September. A reality check for GLP-1 and other weight loss stocks. Finding the next great disruptor that could be hiding in plain sight. Companies discussed: VKTX, NVO, LLY, UNH, TREX, DIS, TBBB, LEN  Host: Rick Munarriz, Karl Thiel, Jason Hall  Producer: Anand Chokkavelu Engineer: Bart Shannon Learn more about your ad choices. Visit megaphone.fm/adchoices

Understanding Risk: International Investing Insights with Tyler CroweIn this month's Misfit Monthly Episode, Jason Hall and Tyler Crowe delve into the concept of risk in investing. They discuss the broad definitions and perceptions of risk, focusing particularly on the differences between volatility and the probability of permanent loss of capital. The conversation also explores the common view that international markets are considered risky, using examples like Poland and Mexico to show that's not always the case. Tyler shares insights from his extensive experience living and investing overseas, emphasizing the importance of evaluating unfamiliar markets and the risks associated with them. The episode aims to equip investors with the tools to better assess risk and make informed decisions that align with their financial goals.01:04 Defining Risk in Investing21:17 Perceptions of Risk in International Markets24:06 The Granny Shot: A Lesson in Unconventional Success24:51 Societal Pressure in Decision Making26:10 Investment Community and Benchmark Hugging27:42 Incentives and Fund Management30:56 Stock Buybacks and Market Signals33:39 Evaluating Risk in International Markets41:09 Final Thoughts on Risk and Investment Strategies*****************************************Check out Tyler's Misfit Alpha at https://www.misfitalpha.com/unscripted Follow Tyler on BlueSky: https://bsky.app/profile/misfit-alpha.bsky.socialJoin our PatreonSubscribe to our portfolio on Savvy Trader *****************************************Email: investingunscripted@gmail.comTwitter: @InvestingPodCheck out our YouTube channel for more content: ******************************************To get 15% off any paid plan at finchat.io, visit https://fiscal.ai/unscripted******************************************Listen to the Chit Chat Stocks Podcast for discussions on stocks, financial markets, super investors, and more. Follow the show on Spotify, Apple Podcasts, or YouTube******************************************2025 Portfolio Contest2024 Portfolio Contest2023 Portfolio Contest

Summer is heating up, but restaurant stocks are cooling down. Today on Motley Fool Money, Rick Munarriz, with analysts Alicia Alfiere and Jason Hall will dig into problems at your favorite chains. There's also a look at some companies reporting earnings this week and it's report card time for some of this year's biggest gainers.They unpack: Three companies worth watching are reporting earnings this week. Sluggish comps at many leading restaurants. A few unexpected stocks have more than doubled this year. Can they keep the upticks coming? Companies discussed: CMG, CAVA, WING, SG, MCD, TJX, VIK, BIDU, CELH, RBLX, PLTR Host: Rick Munarriz, Jason Hall, Alicia Alfiere Producer: Anand Chokkavelu Engineer: Dan Boyd, Natasha Hall Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. We're committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode. Learn more about your ad choices. Visit ⁠⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Having a stock you own getting acquired at a premium feels good at first, but what about the long-term gains that will be left behind when your chips are off the table? Today on Motley Fool Money, Rick Munarriz, with analysts Karl Thiel and Jason Hall will dig into four growth stocks ripe for the acquiring. There's also two sides to Tesla's changing AI story and a new kind of stock quote game. They unpack: - Tesla throwing in the towel on its AI supercomputer initiative. - Four potential buyout candidates after another Rule Breaker agreed to be acquired. - A CEO quote challenge. Companies discussed: TSLA, LULU, VKTX, BMRN, ROKU Host: Rick Munarriz, Karl Thiel, Jason Hall Producer: Anand Chokkavelu Engineer: Dan Boyd Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. We're committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode. Learn more about your ad choices. Visit megaphone.fm/adchoices

I'm Dr. Jason Hall, board-certified plastic surgeon and author of The Art of Aging. Today, I'm busting the top 5 myths surrounding Botox and dermal fillers. Whether you're curious about wrinkle prevention, worried about looking “fake,” or wondering if injectables are safe, this episode gives you real, no-fluff answers straight from the source.You'll learn:What Botox actually treats and what it doesn'tThe truth about filler longevity (hint: it's not what the ads say)Why looking fake has more to do with your injector than the productWhen to start facial rejuvenation (it's not about age, it's about anatomy)What you should know about safety and complicationsIf you've ever considered non-surgical facial treatments or want to understand what's happening behind the scenes in med spas and aesthetic clinics, this is your episode.Grab my book → The Art of Aging on AmazonHave a question or show idea?DM me on Instagram @drjasonhall or email info@drjasonhall.com

From overvalued stocks to outsized returns, some capital compounders keep breaking the mold. Today on Motley Fool Money, Emily Flippen, with analysts Sanmeet Deo and Jason Hall, dig into four market beaters and ask: can the flywheels keep spinning? They unpack: - Earnings from old-school winners Axon and MercadoLibre, including how they turned skeptics into believers with consistent execution - Results from new-school contenders Hims & Hers and Palantir, both of which face high levels of scrutiny despite strong performance - Tariff math that matters and where pricing power may blunt cost headwinds Companies discussed: MELI, AXON, HIMS, PLTR, ZBRA Host: Emily Flippen, Sanmeet Deo, Jason Hall Producer: Anand Chokkavelu Engineer: Dan Boyd, Natasha Hall Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit ⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Women over 45 are the #1 demographic for cosmetic procedures—but what are they actually choosing, and why?I'm board-certified plastic surgeon Dr. Jason Hall, and in this solo episode I'm going to break down the top trends driving aesthetic decisions in 2025 for women over 45. From non-surgical facial rejuvenation and the rise of body contouring (thanks, Ozempic) to deep plane facelifts and hormone optimization, I'll cut through the fluff to give you the real story: what works, what's hype, and what's next.You'll learn:Why injectables, lasers, and RF microneedling remain go-to treatmentsWhat GLP-1 medications like Ozempic are doing to demand for tummy tucks and body liftsHow deep plane facelifts are changing the facelift gameWhy hormone optimization is the new frontier in looking and feeling youngerThis isn't your average anti-aging talk. It's smart, straightforward insight from someone who knows the industry inside and out, and who's not afraid to say what others won't.- Grab The Art of Aging on Amazon - Questions or show ideas? DM @drjasonhall or email info@drjasonhall.com - Subscribe to The Trillium Show for more real talk on plastic surgery and aesthetics

With Block joining the S&P500 and Figma pricing its IPO, investors may be wondering if they should be rising with the tide or fishing where others are not.Emily Flippen, Jason Hall, and Sanmeet Deo discuss: Whether or not it makes sense to "buy the add" when a stock is added to an index Figma's drive to enter public markets and its current valuation Contrarian investment ideas for beaten-down rule breakers Companies discussed: XYZ, FIG, ROKU, PTON, W,  ETSYHost: Emily Flippen, Jason Hall, Sanmeet DeoProducer: Anand ChokkaveluEngineer: Dan Boyd, Adam LandfairDisclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit ⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Earnings season is here! Jason Hall and Matt Frankel discuss: - Netflix's beat and raise. - Interest rate predictions for a year from now. - Crypto week's three bills, including the GENIUS Act. And how we personally invest in cryptocurrency. - The best (and worst) big bank earnings. - How we invest with our kids. - Stocks on our radar. Stocks discussed: NFLX, Bitcoin, Ethereum, JPM, C, BAC, WFC, MELI, LOB, RKT Host: Anand Chokkavelu Guests: Jason Hall, Matt Frankel Engineer: Dan Boyd Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, "TMF") do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit megaphone.fm/adchoices

Get excited…today is the first day of earnings season! (00:21) Anand Chokkavelu, Emily Flippen, Jason Hall, and Jose Najarro discuss: - Inflation ticks up - NVIDIA and semiconductors get a China bump - The big banks kick off earnings season (and tell us about the economy) - Is “Crypto Week” a thing? - Bold predictions on which company will surprise this earnings season Companies discussed: NVDA, AMD, JPM, WFC, C, Bitcoin, ETSY, CFLT, WBD Host: Anand Chokkavelu Guests: Emily Flippen, Jason Hall, Jose Najarro Engineer: Dan Boyd Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, "TMF") do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit megaphone.fm/adchoices

Oh yes, we're talking all kinds of stocks! (00:21) Jason Hall and Matt Frankel discuss: - AI stocks in the data center space (including CoreWeave) - Winners and losers in energy and solar from the Big Beautiful Bill. - With Superman coming out, we rank the intellectual property of Warner Bros. Discovery, Comcast, Disney, and Netflix (19:11) Dave Schaeffer, founder and CEO of Cogent Communications, talks with Asit Sharma and Sanmeet Deo about how Cogent's deals with customers like Netflix and Meta Platforms work and what keeps him up at night. (32:39) Jason and Matt talk about Prime Day and other made up holidays and give us the stocks on their radar. Stocks discussed: CRWV, DLR, EQIX, AMZN, MSFT, BEP, BEPC, NVDA, CRM, CSIQ, RUN, FSLR, ENPH, TSLA, GEV, J, CEG, FLNC, WBD, CMCSA, DIS, NFLX, SOFI, CHD Host: Anand Chokkavelu Guests: Jason Hall, Matt Frankel, Asit Sharma, Sanmeet Deo, Dave Schaeffer Engineer: Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices

Thinking about opening a med spa? You've seen the rise: new med spas popping up on every corner, flashy marketing, and $500 treatments, but is the business really as profitable as it looks?I'm your host Dr. Jason Hall and in this episode of The Trillium Show, I'm pulling back the curtain on the economics of the med spa industry. From startup costs and overhead to hidden expenses and private equity myths, he walks you through the real numbers, hard lessons, and what it actually takes to build a med spa that lasts.You'll learn:What the average med spa really earns (and what's just hype)How long it typically takes to turn a profit—and whyThe biggest mistakes people make with devices, overhead, and debtWhy controlling your costs and prioritizing patient care is non-negotiableWhat private equity is looking for, and whether it's worth chasingIf you're a physician, injector, or entrepreneur eyeing the med spa world, this is your reality check, and your playbook.

Looking at the company and stock behind the summer shopping event. (00:21) Anand Chokkavelu, Jason Hall, and Matt Frankel discuss: - The Aug.1 tariffs - This year's four-day Prime Day (and whether Amazon stock is a deal) - Elon Musk's political party and Tesla - Bold predictions Companies discussed: AMZN, TSLA Host: Anand Chokkavelu Guests: Jason Hall, Matt Frankel Engineer: Dan Boyd Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, "TMF") do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit megaphone.fm/adchoices

Nike stock moves higher after Q4 earnings. Andy Cross and Jason Hall discuss - Why Nike stock rallied after its latest earnings - Also: Home Depot to buy GMS for $5.5 billion - And will F1 the Movie drive Apple's stock? Companies discussed: NKE, HD, GMS, QXO, AAPL, NFLX, AMZN Host: Andy Cross Guests: Jason Hall Engineer: Dan Boyd Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, "TMF") do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit megaphone.fm/adchoices

Are non-surgical facelifts worth the hype—or just a waste of money? I'm your host, Dr. Jason Hall, and in this solo episode I break down the truth about the most popular non-surgical facial rejuvenation treatments. We'll cover lasers, radiofrequency microneedling, fillers and thread lifts, and why so many of these options fall short, especially if you're expecting facelift-level results.You'll learn:- Why “non-surgical facelift” is often a misleading label- The four true causes of facial aging, and why no single treatment solves them all- What lasers, RF, and fillers actually do (and what they definitely don't)- Why thread lifts are basically “cosmetic sugar highs”- How to approach diagnosis before you invest in any treatmentWhether you're considering aesthetic treatments or just want to understand what works and what's marketing fluff, this episode will give you the clarity you need to make smart, informed decisions.Grab a copy of my book The Art of Aging for an even deeper dive.

FICO turns to BNPL data and Fiserv embraces a new stablecoin. Andy Cross, Jason Hall, and Matt Frankel discuss: - FICO to include BNPL data - The importance of Tesla's robotaxi - Tesla's advantages and challenges in self-driving - Fiserv launches its own stablecoin Companies discussed: FICO, TSLA, GOOGL, UBER, FI, PYPL, CRCL, SHOP Host: Andy Cross Guests: Jason Hall, Matt Frankel Engineer: Dan Boyd Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, "TMF") do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit megaphone.fm/adchoices

Solar stocks take a tumble. (00:21) Anand Chokkavelu, Jason Hall, and Matt Frankel discuss: - Why solar stocks are falling today. - Lennar earnings. - How to think of your house: asset vs. investment. - Matt & Jason's top 3 homebuilders. Companies discussed: ENPH, RUN, FSLR, SEDG, CSIQ, LEN, GRBK, MTH, LGIH, DFH, NVR Host: Anand Chokkavelu Guests: Jason Hall, Matt Frankel Engineer: Dan Boyd Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, "TMF") do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit megaphone.fm/adchoices

Vaccines are often hailed as one of the greatest medical achievements of the 20th century, but what if that story is missing some key chapters?I'm Dr. Jason Hall, and in this episode of The Trillium Show, I sit down with Roman Bystrianyk, co-author of Dissolving Illusions, for a conversation that made me question everything I was taught in medical school about disease, immunity, and the history of vaccines.Roman's research takes us beyond the standard “one germ, one drug” model and into terrain theory, which suggests that a healthy internal environment, not just microbial exposure, determines whether we get sick. We dig into historical data showing massive declines in infectious diseases like measles, scarlet fever, and whooping cough long before vaccines were introduced, thanks to improvements in sanitation, nutrition, and public health.We also talk about:Why terrain theory might matter more today than everHow modern medicine's financial incentives shape what we're taughtWhy critical thinking is your most powerful tool in any doctor's officeThe potential downsides of overrelying on vaccines as a cure-allAnd how you can take real ownership of your health and immune systemThis isn't a call to ignore science, it's an invitation to ask better questions and take a deeper look at what health really means.- Grab Dissolving Illusions or visit dissolvingillusions.com- Check out Roman's Substack for more independent research- DM me @drjasonhall or leave a comment if this episode challenged your thinkingIf you've ever wondered whether we've been oversimplifying complex health issues, this one's for you.

Warner Bros. Discovery is planning to break itself up into two distinct companies. (00:21) Andy Cross and Jason Hall discuss: - Warner Bros. Discovery splits up. - How does it affect the streaming game of thrones? - Reddit vs. Claude Companies discussed: WBD, NFLX, DIS, CMCSA, RDDT Host: Andy Cross Guests: Jason Hall Producer: Anand Chokkavelu Engineer: Dan Boyd Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, "TMF") do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit megaphone.fm/adchoices

Which stock will have the best ice cream and beach season? (00:21) Anand Chokkavelu, Jason Hall, and Matt Frankel discuss: - Jason's and Matt's picks for the stock of the summer. - “News or Noise” with Dollar General, Disney, and Meta. - “Buy, Sell, or Meh” with the same three companies. Companies discussed: EPR, AMD, SNOW, DIS, META Build your Range Rover Sport at www.rangerover.com/us/sport Host: Anand Chokkavelu Guests: Jason Hall, Matt Frankel Producer: Ricky Mulvey Engineer: Dan Boyd Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, "TMF") do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit megaphone.fm/adchoices

If you're building a career, starting a business, or just trying to grow into the next version of yourself—this episode is for you.I'm Dr. Jason Hall, and today on The Trillium Show, I'm getting personal. We're talking about mentorship: why it matters, how I neglected it in my own life, and the real costs of trying to figure everything out on your own.I've made more mistakes than I can count, many of them because I let pride get in the way of asking for help. But here's the truth: mentors don't see your questions as weakness. They see them as connection. And if you want to build something meaningful, whether that's a surgical practice, a small business, or just a fulfilling life, you can't do it alone.In this episode, I share:The 3 biggest benefits of finding the right mentorWhy going it alone can cost you time, energy, and moneyHow mentorship helps you avoid burnout and isolationWhat I've learned mentoring young surgeons, students, and entrepreneursAnd why asking for help might be the strongest move you makeThis isn't a step-by-step guide. It's a real-world reminder that success is a team sport. So if you've ever felt stuck, overwhelmed, or too proud to reach out, I hope this message helps you change that.- Grab a copy of The Art of Aging: Look Great, Not Fake on Amazon - DM me on Instagram @drjasonhall with your questions - And don't forget to subscribe, more solo episodes like this are coming soon.

Fed Chair Powell and team want to see more before making changes to interest rates, and automakers are an early sign price increases might be coming in response to tariffs. (00:21) Tim Beyers and Bill Mann discuss: - The Fed's continued wait and see approach to tariff policy, inflation, and interest rate cuts. - Ford's warning of tariff impacts, and why MercadoLibre is worth a look amid the macro uncertainty. - How Uber and DoorDash are both flourishing as they cash in on the delivery market and consumer laziness. (19:11) Fool contributor Jason Hall talks through his time at Berkshire Hathaway's annual meeting in Omaha, Warren Buffett's plans to step down as CEO, and what to expect next from Greg Abel. (31:12) Bill and Tim break down two stocks on their radar: Apple and Ibotta. Stocks discussed: F, MELI, DASH, UBER, NVO, BRK.A, BRK.B, AAPL, BAC, IBT Host: Dylan Lewis Guests: Bill Mann, Tim Beyers, Jason Hall Engineers: Dan Boyd Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, "TMF") do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit megaphone.fm/adchoices

“Liberation Day” has arrived. (00:21) David Meier and Mary Long discuss: - When we'll know if the longer-term tariff plan is working. - How different companies are bracing for impact. - Tesla's sales slump. Then, (16:23), Fool contributor Jason Hall joins Ricky Mulvey for a look at Texas Instruments and Taiwan Semiconductor. Companies discussed: WMT, TSLA, TXN, TSM Host: Mary Long Guests: David Meier, Ricky Mulvey, Jason Hall Engineer: Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices

The company behind the iPhone aspires for its “greatest contribution” to be beyond personal computing. (00:21) Jason Moser and Mary Long discuss xAI's latest purchase, Apple's healthcare endeavors, and what Larry Fink is looking forward to. Then, (19:50), Anand Chokkavelu hosts Fool contributors Jason Hall and Tyler Crower for a Scoreboard episode on Next Era Energy. To become a premium Motley Fool member and gain access to all Scoreboard episodes, go to www.fool.com/signup. Companies mentioned: TSLA, META, AAPL, BLK, NEE Host: Mary Long Guests: Jason Moser, Anand Chokkavelu, Tyler Crowe, Jason Hall Producer: Ricky Mulvey Engineers: Dan Boyd, Michael Schweitzer Learn more about your ad choices. Visit megaphone.fm/adchoices

March 2025 brings another This Month in Birding featuring a panel of birding friends here to talk about the month's new bird news and get ready for spring. This time around we welcome Jennie Duberstein, Bird Joy Pod's Jason Hall, and Nicole Jackson to talk plastics in seabirds, new eyes on old maps, and the best bird to party with. Links to articles discussed in this episode: Fifty years of songbird maps take flight in new hands Plastic pollution leaves seabirds with brain damage similar to Alzheimer's, study shows How a hummingbird chick acts like a caterpillar to survive Coming off dry January, these birds are getting a little drunk Subscribe to the podcast at Apple Podcasts, Spotify, or wherever you get your podcasts and please leave a rating or a review if you are so inclined! We appreciate it!

Now he wants to run OpenAI. (00:21) Jason Moser and Mary Long discuss: - Elon Musk's bid for OpenAI - What BYD's rollout of self-driving technology means for Tesla - Revitalized interest in Upstart's AI lending platform - Developments in the buy now, pay later space Then, (17:39), Anand Chokkavelu hosts Fool contributors Jason Hall and Rick Munarriz for a Scoreboard episode breaking down Trex, the composite decking company. To become a premium Motley Fool member and gain access to all Scoreboard episodes, go to www.fool.com/signup. Companies mentioned: MSFT, TSLA, BYD, UPST, JPM, AFRM, FIS, TREX Host: Mary Long Guests: Jason Moser, Anand Chokkavelu, Jason Hall, Rick Munarriz Producer: Ricky Mulvey Engineers: Dan Boyd, Michael Schweitzer Learn more about your ad choices. Visit megaphone.fm/adchoices